Submitted by Anonymous (not verified) on 19 September 2024 - 13:32
Opinion/decision on a Paediatric investigation plan (PIP): Hepcludex, Bulevirtide, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infectious diseases, PIP number: P/0270/2022
Source: